Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Early diagnosis and aggressive treatment of lupus nephritis can prevent kidney damage and improve outcomes.

The SBN system effectively assesses alopecia areata severity and predicts its course.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Norwegian puffin dogs have a unique type of hair loss that often doesn't get better on its own and responds well to ciclosporin treatment.

Co-trimoxazole successfully treated a girl with multiple autoimmune symptoms.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.

Higher IL-17A levels indicate more severe alopecia areata.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

The document says that there are treatments for hair and nail diseases.

The document describes skin diseases affecting the outer ear in dogs and cats, their spread to other body parts, and treatment options.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.